# Adaptive Biotechnologies Reports First Quarter 2026 Financial Results
Canonical URL: https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-reports-first-quarter-2026-financial-results
Ticker: ADPT
Company: Adaptive Biotechnologies
Source: Adaptive Biotechnologies
Published: 2026-05-05 20:05 EST
Original Source URL: https://investors.adaptivebiotech.com
## Summary

SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported

## Article Body
SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported
## Recent Company News
- 2026-05-29 11:30 EST — [At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research](https://biopharmsignal.com/news/ADPT/at-asco-and-eha-2026-new-data-reinforce-the-pivotal-role-of-clonoseqr-mrd-testing-across-hematology-clinical-practice-and-research) — Source: Adaptive Biotechnologies
- 2026-05-05 20:05 EST — [Adaptive Biotechnologies Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-reports-first-quarter-2026-financial-results) — Source: Adaptive Biotechnologies
- 2026-04-15 20:05 EST — [Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026](https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026) — Source: Adaptive Biotechnologies
- 2026-02-05 21:05 EST — [Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results](https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-reports-fourth-quarter-and-full-year-2025-financial-results) — Source: Adaptive Biotechnologies
- 2026-01-27 21:05 EST — [Adaptive Biotechnologies to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-to-participate-in-upcoming-investor-conferences) — Source: Adaptive Biotechnologies
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)